• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies regarding how exposure over time may affect the pregnant fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the benefits of taking them against potential risks to the fetus. Physicians do not have the necessary data to give clear guidelines, but they can provide information regarding risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry found that women who prescribes adhd medication took adhd medication adults uk medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major structural birth defects. The researchers used a large population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists examined the cases to ensure an accurate case classification and to minimize the possibility of bias.

However, the study had its limitations. Most important, they were unable to separate the effects of the medication from the underlying disorder. This makes it difficult to determine whether the small differences observed in the exposed groups result from medication use or comorbidities that cause confusion. Researchers also did not study the long-term effects for the offspring.

The study did show that infants whose mothers took ADHD medication during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk for admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a baby with low Apgar score (less than 7). These increases didn't appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medication during pregnancies in the early stages could be offset by the more beneficial outcomes for both baby and mother of continued treatment for [Redirect-302] the woman’s disorder. Physicians should discuss this with their patients and, when possible, help them develop strategies to improve coping skills that can lessen the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether or not to discontinue treatment during pregnancy is one that more and more doctors have to face. The majority of these decisions are made in the absence of clear and authoritative evidence either way, so physicians must weigh what they know about their experiences, the experiences of other doctors, and what the research says on the topic as well as their own judgments for each individual patient.

Particularly, the subject of possible risks to the baby can be tricky. The research that has been conducted on this topic is based on observations rather than controlled studies and the results are conflicting. The majority of studies focus on live births, which can underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these limitations by analyzing the data from deceased and live births.

The conclusion The conclusion: While some studies have found an association between ADHD medications and the risk of certain birth defects, others have found no such relationship, and most studies have a neutral or slightly negative effect. In every case an in-depth analysis of the benefits and risks should be conducted.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In fact, in a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation and family conflict for those suffering from the disorder. The loss of medication can affect the ability to drive safely and to perform work-related tasks which are essential aspects of everyday life for those suffering from ADHD.

She suggests women who are unsure about whether to keep or discontinue medication due to their pregnancy should consider educating family members, friends, http://www.glaminstar.co.kr/gnu5/bbs/board.php?bo_table=free&wr_id=61337 and coworkers on the condition, its effects on daily functioning, and the benefits of keeping the current treatment plan. It can also help women feel supported in her decision. Some medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it's important to be aware that the medication could be transferred to the baby.

Risk of Birth Defects

As the use and misuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (adhd medication private prescription - www.Metooo.Com -), increases, so does concern about the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Using two massive data sets, researchers were able to look at more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication use was associated with slightly higher risk of specific heart defects like ventriculoseptal defect.

The authors of the study didn't discover any connection between early medication usage and congenital anomalies such as facial deformities or club feet. The results are in line with previous studies that have shown the existence of a slight, but significant increase in the number of cardiac malformations among women who started taking ADHD medication before pregnancy. The risk grew in the latter half of pregnancy, when many women are forced to stop taking their ADHD medication.

Women who used ADHD medication for adhd and depression in the first trimester of pregnancy were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby who required breathing assistance during birth. However, the authors of the study were not able to eliminate bias due to selection by limiting the study to women who did not have any other medical issues that could have contributed to the findings.

Researchers hope that their study will inform physicians when they see pregnant women. They advise that while a discussion of the risks and benefits is crucial, the decision to stop or continue treatment should be based on the woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is an option to think about, it isn't advised because of the high incidence of depression and other mental disorders in women who are expecting or have recently given birth. Additionally, the research suggests that women who choose to stop taking their medication are more likely to have a difficult time getting used to life without them following the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and getting used to new routines at home may face a lot of challenges. Many women opt to continue taking their adhd over the counter medication uk medication during pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at a low level. However, the rate of medication exposure to the infant can differ based on the dosage, frequency it is administered, and the time of day it is administered. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn infant is not well understood.

Due to the absence of research, some doctors may recommend stopping stimulant medications during a woman's pregnancy. This is a difficult decision for the patient, who must balance the benefits of keeping her medication against the possible dangers to the fetus. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication without risk while breastfeeding and during pregnancy. In the end, more and more patients opt to do this and, after consulting with their doctor, they have discovered that the benefits of keeping their current medication far outweigh any potential risks.

Women with ADHD who plan to breastfeed should seek advice from an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help pregnant people with adhd without medication understand their symptoms and the underlying disorder and learn about treatments and to reinforce existing coping strategies. This should be a multidisciplinary approach with the GP, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, monitoring of indicators of deterioration, and, if necessary modifications to the medication regime.